Form 4: Camp4 Therapeutics Director Andrew Schwab Reports Conversion of Preferred Stock to Common Stock Following IPO

Sentiment:

SEC Form 4 Filing


Director Andrew Schwab reports the conversion of preferred stock to common stock and a purchase of common stock following Camp4 Therapeutics' initial public offering.

Summary

  • On October 15, 2024, Andrew Schwab, a director of Camp4 Therapeutics Corp, filed a Form 4 with the SEC.
  • The filing reports the automatic conversion of Series A Prime and Series B Preferred Stock into Common Stock upon the closing of Camp4 Therapeutics' initial public offering (IPO).
  • The Series A Prime Convertible Preferred Stock converted on a 11.2158-for-one basis, resulting in 1,337,592 shares of Common Stock.
  • The Series B Preferred Stock also converted on a 11.2158-for-one basis, resulting in 378,463 shares of Common Stock held by 5AM Ventures VI, L.P. and 302,770 shares held by 5AM Opportunities II, L.P.
  • Schwab also reported purchasing 909,090 shares of Common Stock at a price of $11 per share.
  • Following these transactions, Schwab indirectly beneficially owns 2,625,145 shares through 5AM Ventures VI, L.P. and 5AM Opportunities II, L.P.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The conversion of preferred stock is a standard post-IPO event, and the director's purchase of shares suggests confidence in the company.

Positives

  • The conversion of preferred stock to common stock simplifies the company's capital structure following the IPO.
  • Andrew Schwab's purchase of 909,090 shares at $11 indicates confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice after an IPO, as insiders adjust their holdings and report changes in beneficial ownership. This filing indicates the conversion of preferred shares held by venture capital firms into common stock, which is a typical step following an IPO.

Comparison to Industry Standards

  • Form 4 filings are a standard regulatory requirement for company insiders following significant transactions, such as an IPO.
  • The conversion of preferred stock to common stock is a common occurrence after an IPO, as it simplifies the company's capital structure.
  • Director purchases of company stock after an IPO are often viewed positively by the market, as they signal confidence in the company's future prospects.

Stakeholder Impact

  • The conversion of preferred stock to common stock may have a slight dilutive effect on existing shareholders.
  • The director's purchase of shares could be viewed positively by shareholders, as it signals confidence in the company's future.

Key Dates

DateDescription
10/15/2024Date of earliest transaction (conversion of preferred stock and purchase of common stock).
10/15/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.